Pharmaceutical giant Pfizer has initiated legal action to block a rival takeover attempt of the drugmaker Metsera by Denmark’s Novo Nordisk. The lawsuit marks a significant escalation in the high-stakes battle for control of the promising biotech firm, highlighting the intensifying competition between two of the industry’s leading companies. As both Pfizer and Novo Nordisk vie to expand their portfolios in the lucrative specialty drug market, the outcome of this dispute could have far-reaching implications for the future landscape of pharmaceutical innovation and consolidation.
Pfizer Takes Legal Action to Block Novo Nordisk’s Hostile Bid for Metsera
Pharmaceutical giant Pfizer has initiated legal proceedings aimed at halting Denmark-based Novo Nordisk’s aggressive acquisition attempt of Metsera, a key player in the biopharmaceutical sector. The lawsuit, filed in a U.S. federal court, challenges the legitimacy of Novo Nordisk’s hostile bid, citing concerns over regulatory…
—-
Author : Isabella Rossi
Publish date : 2025-11-02 23:56:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8
